Erpeng Yang

Prognostic value of ASXL1 mutations in patients with primary myelofibrosis and its relationship with clinical features: a meta-analysis

Xiaomei Hu, Wei-yi Liu, Ziqing Wang, 2021, Annals of Hematology.

Comparison of the effects between MPL and JAK2V617F on thrombosis and peripheral blood cell counts in patients with essential thrombocythemia: a meta-analysis

Xiaomei Hu, Wei-yi Liu, Hai-yan Xiao, 2021, Annals of Hematology.

Metabolic Biomarkers Affecting Cell Proliferation and Prognosis in Polycythemia Vera

Mingqian Sun, Xiaomei Hu, Wei-yi Liu, 2022, Cancers.

TET2 Mutation May Be More Valuable in Predicting Thrombosis in ET Patients Compared to PV Patients: A Preliminary Report

Xiaomei Hu, Wei-yi Liu, Yumeng Li, 2022, Journal of clinical medicine.

The active ingredients and mechanisms of Longchai Jiangxue Formula in treating PV, based on UPLC/Q-TOF-MS/MS, systematic pharmacology, and molecular biology validation.

Hongwei Wu, Xiaomei Hu, Wei-yi Liu, 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

The roles and functions of Paneth cells in Crohn’s disease: A critical review

Jun Shen, Erpeng Yang, 2020, Cell proliferation.

Proteomic-Based Platelet Activation-Associated Protein SELP May Be a Novel Biomarker for Coagulation and Prognostic in Essential Thrombocythemia

J. Niu, Xiaomei Hu, Wei-yi Liu, 2023, Journal of clinical medicine.

Coagulation status and determinants of possible aspirin resistance in patients with essential thrombocythemia

J. Niu, Xiaomei Hu, Wei-yi Liu, 2022, Frontiers in Medicine.

Engineering nanobodies for next-generation molecular imaging.

Gang Huang, Jianju Liu, Weijun Wei, 2022, Drug discovery today.